Merck KGaA 2Q Net Profit Soared; Backs Outlook
August 08 2019 - 12:47AM
Dow Jones News
By Carlo Martuscelli
Merck KGaA (MRK.XE) said Thursday that net profit in the second
quarter rose by 90% as net sales increased, and it backed its
full-year outlook.
The German pharmaceuticals and chemicals company made a net
profit of 471 million euros ($527.9 million), up from EUR247
million the prior-year period, on net sales that rose 6.9% to
EUR3.97 billion. On an organic basis, net sales grew 5.6%.
The company said that all three of its business sectors
contributed to topline growth. The life-science business in
particular had a positive performance, achieving 9% organic sales
growth, Merck said.
The closely watched company metric Ebitda pre--or earnings
before interest, taxes, depreciation and amortization before
one-time items--totaled EUR1.14 billion, up from EUR920 million
last year.
The company backed its 2019 outlook. It continues to expect net
sales for the year of between EUR15.3 billion and EUR15.9 billion.
Ebitda pre for 2019 is forecast at between EUR4.15 billion and
EUR4.35 billion.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
August 08, 2019 01:32 ET (05:32 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2024 to May 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From May 2023 to May 2024